Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Immatics (IMTX)
NASDAQ:IMTX
Immatics (IMTX) Stock Price & Analysis
213 Followers
IMTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.90 - $13.60
Previous Close$10.09
Volume378.95K
Average Volume (3M)426.58K
Market Cap
$788.17M
Enterprise Value$639.65M
Total Cash (Recent Filing)€148.52M
Total Debt (Recent Filing)€14.56M
Price to Earnings (P/E)20.9
Beta0.72
Next Earnings
Aug 08, 2023EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.48
Shares Outstanding76,670,000
10 Day Avg. Volume452,264
30 Day Avg. Volume426,577
Standard Deviation0.15
R-Squared0.06
Alpha0.00034
Financial Highlights & Ratios
Price to Book (P/B)3.68
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$18.25Price Target Upside80.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Immatics News
Pre-EarningsImmatics N.V. (IMTX) Q1 Earnings Cheat Sheet
Stock Analysis & IdeasTipRanks ‘Perfect 10’ List: These 2 Top-Rated Stocks Could Be Long-Term Winners
IMTX FAQ
What was Immatics’s price range in the past 12 months?
Immatics lowest stock price was $5.90 and its highest was $13.60 in the past 12 months.
What is Immatics’s market cap?
Currently, no data Available
When is Immatics’s upcoming earnings report date?
Immatics’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
How were Immatics’s earnings last quarter?
Immatics released its earnings results on May 16, 2023. The company reported -$0.278 earnings per share for the quarter, beating the consensus estimate of -$0.291 by $0.013.
Is Immatics overvalued?
According to Wall Street analysts Immatics’s price is currently Undervalued.
Does Immatics pay dividends?
Immatics does not currently pay dividends.
What is Immatics’s EPS estimate?
Immatics’s EPS estimate is -$0.28.
How many shares outstanding does Immatics have?
Immatics has 76,670,700 shares outstanding.
What happened to Immatics’s price movement after its last earnings report?
Immatics reported an EPS of -$0.278 in its last earnings report, beating expectations of -$0.291. Following the earnings report the stock price went down -1.992%.
Which hedge fund is a major shareholder of Immatics?
Among the largest hedge funds holding Immatics’s share is Baker Bros Advisors LP. It holds Immatics’s shares valued at 36M.
---
Immatics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.25 (80.87% Upside)
$18.25 (80.87% Upside)
Blogger Sentiment
Bullish
IMTX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 978.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 9.5%
Last 30 Days ▲ 9.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.45%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
30.97%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Immatics
Immatics NV is engaged in discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's pipeline consists of two lead product classes, engineered Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics (TCER). Each therapeutic modality has distinct attributes to produce the desired therapeutic effect for patients at different disease stages and with different types of tumors focusing on particularly hard-to-treat solid cancers.
---
Top 5 ETFs holding IMTX
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold IMTX. The ETFs are listed according to market value of IMTX within the ETF
---
---